Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab

J Investig Allergol Clin Immunol. 2020;30(5):378-379. doi: 10.18176/jiaci.0564. Epub 2020 May 6.

Authors

L Bernal-Rubio¹, B de-la-Hoz Caballer^{1

2}, C Almonacid-Sánchez³, D González-de-Olano^{1

2}

Affiliations

¹ Allergy Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
² Spanish Thematic Network and Co-operative Research Centers, ARADyAL.
³ Pneumology Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.

PMID: 32376515
DOI: 10.18176/jiaci.0564

No abstract available

Keywords: Allergic bronchopulmonary aspergillosis; Asthma; Benralizumab; Omalizumab.

Publication types

Case Reports

MeSH terms

Adrenal Cortex Hormones / administration & dosage
Aged
Anti-Allergic Agents / administration & dosage
Anti-Allergic Agents / adverse effects
Anti-Allergic Agents / therapeutic use*
Antibodies, Monoclonal, Humanized / administration & dosage
Antibodies, Monoclonal, Humanized / adverse effects
Antibodies, Monoclonal, Humanized / therapeutic use*
Aspergillosis, Allergic Bronchopulmonary / diagnosis
Aspergillosis, Allergic Bronchopulmonary / drug therapy*
Aspergillosis, Allergic Bronchopulmonary / immunology*
Aspergillosis, Allergic Bronchopulmonary / microbiology
Aspergillus / drug effects
Aspergillus / immunology*
Biomarkers
Drug Resistance
Humans
Immunoglobulin E / blood
Immunoglobulin E / immunology
Male
Omalizumab / therapeutic use
Respiratory Function Tests
Symptom Assessment
Treatment Outcome

Substances

Adrenal Cortex Hormones
Anti-Allergic Agents
Antibodies, Monoclonal, Humanized
Biomarkers
Omalizumab
Immunoglobulin E
benralizumab